Fidelity International
CHRS icon

Fidelity International’s Coherus Oncology CHRS Stock Holding History

Fidelity International’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-324,589
Closed -$5.26M – 878
2020
Q1 		$5.26M Sell
324,589
-209,620
-39% -$3.87M 0.01% 511
2019
Q4 		$9.62M Buy
534,209
+63,812
+14% +$1.18M 0.01% 508
2019
Q3 		$9.53M Hold
470,397
– – 0.01% 484
2019
Q2 		$10.4M Buy
+470,397
New +$8.17M 0.02% 463
2015
Q4 		– Sell
-160,152
Closed -$3.21M – 494
2015
Q3 		$3.21M Buy
+160,152
New +$4.87M 0.01% 414

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fidelity International's CHRS Position: Q2 2020 in Review

Fidelity International sold out of Coherus Oncology (CHRS) in Q2 2020, closing a stake of 324,589 shares — an estimated $5.26M sold.

Fidelity International first reported a position in CHRS in Q3 2015 and held it in 5 quarters. The position peaked at $10.4M in Q2 2019. 188 funds tracked by Wall St. Rank hold CHRS as of Q2 2020.

  • Fidelity International reported no remaining Coherus Oncology position as of Q2 2020 after selling out during the quarter.
  • Fidelity International sold 324,589 Coherus Oncology shares in Q2 2020, an estimated $5.26M.
  • Fidelity International first reported a position in Coherus Oncology in Q3 2015 and held it in 5 quarters.
  • Fidelity International's Coherus Oncology position peaked at $10.4M in Q2 2019.
  • 188 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2020.

Based on Fidelity International's 13F filing for Q2 2020, filed 13 Aug 2020.